PharmaTimes

Clinical research is entering a new era: advances in methodological approaches, the growing integration of real-world evidence, and strengthened patient engagement are reshaping the drug development landscape.1 As the field continues to evolve, an important challenge has emerged: does the evidence we generate truly reflect the populations these medicines are intended to serve? Across industry, […]

Future-ready pharma teams: building knowledge and capability to navigate a changing NHS

Clinical trials are becoming increasingly complex. In a 2023 survey, 70% of investigative site staff said conducting studies had become more difficult over the previous five years. For sponsors, this shows up as delayed decisions, duplicated effort and reduced visibility across their studies. The challenge is rarely a lack of information. More often, it stems […]